Pages that link to "Q44643774"

The following pages link to Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission (Q44643774):

Displaying 12 items.

• Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer (Q33364075) (← links)
• Practical considerations in ovarian cancer chemotherapy (Q35076260) (← links)
• Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up (Q36137624) (← links)
• Are three additional cycles of chemotherapy useful in patients with advanced-stage epithelial ovarian cancer after a complete response to six cycles of intravenous adjuvant paclitaxel and carboplatin? (Q36731762) (← links)
• Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals (Q36987501) (← links)
• A review of the current evidence for maintenance therapy in ovarian cancer (Q37589224) (← links)
• The Role of Intraperitoneal Carboplatin as Consalidation Chemotherapy in Women with Ovarian Carcinoma: Report of Our Experience and Systematic Review (Q37608072) (← links)
• Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics (Q37993908) (← links)
• Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up (Q40100306) (← links)
• Surgical second-look in epithelial ovarian cancer: high recurrence rate after negative results and lack of survival benefit limits its role in standard management (Q41988663) (← links)
• Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer (Q45072382) (← links)
• Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer (Q61853687) (← links)